Kona Medical stretches Series C financing round to $40 million

12/5/2012 | American City Business Journals

Kona Medical has obtained $10 million in Series C financing, advancing the company's total for that round to $40 million. The company, which has created an ultrasound device to treat nerves surrounding the kidney, will use the money to support the development of alternative therapies for patients with resistant hypertension, founder and CEO Michael Gertner said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX